Risperidone for the Treatment of Huntington's Disease Involuntary Movements
Clinical trial NCT04201834 · COMPLETED
Trial details
- NCT number
- NCT04201834
- Sponsor
- University of Rochester
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-13
- Primary completion
- 2023-12-30
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.